Concepedia

Author

Lynn C. Moscinski

Moffitt Cancer CenterORCID

Also Known As

Hui-Yi Lin, L C Moscinski, L. C. MOSCINSKI, L. C. Moscinski, L. Moscinski, L.C. Moscinski, LYNN C. MOSCINSKI, LYNN MOSCINSKI, Lynn C Moscinski, Lynn C. Moscinski

244

Publications

7.2K

Citations

38

H-Index

89

Concepts

All Affiliations

Moffitt Cancer CenterUniversity of South FloridaMolecular Oncology (United States)Florida CollegeJames A. Haley Veterans' Hospital
LC

About

Lynn C. Moscinski is an author at Moffitt Cancer Center specializing in medicine, cell biology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

23

37

4K

2

Health Sciences

8

8

275

3

Engineering

1

1

13

4

Biomedical Engineering

1

1

23

5

Biomolecular Engineering

1

1

45

Lynn C. Moscinski

×

68

Publications

6.4K

Citations

36

H-Index

YearCitations

Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells

Robyn Catlett-Falcone, Terry H. Landowski, Marc M. Oshiro,

Immunity

1999

1.6K

microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma

Jianjun Zhao, Jianhong Lin, Tint Lwin,

Blood

2010

334

Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3

Prince George, Purva Bali, Srinivas Annavarapu,

Blood

2004

322

Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells.

Ramadevi Nimmanapalli, Lianne Fuino, Purva Bali,

PubMed

2003

280

Detection of Submicroscopic Lymph Node Metastases with Polymerase Chain Reaction in Patients with Malignant Melanoma

Xiangning Wang, Richard Heller, Nancy VanVoorhis,

Annals of Surgery

1994

276

RETRACTED: Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas

Xinwei Zhang, Xiaohong Zhao, Warren Fiskus,

Cancer Cell

2012

273

Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors

Pearlie K. Epling‐Burnette, Fanqi Bai, Jeffrey S. Painter,

Blood

2007

219

Cotreatment with Histone Deacetylase Inhibitor LAQ824 Enhances Apo-2L/Tumor Necrosis Factor-Related Apoptosis Inducing Ligand-Induced Death Inducing Signaling Complex Activity and Apoptosis of Human Acute Leukemia Cells

Fei Guo, Celia Sigua, Jianguo Tao,

Cancer Research

2004

201

Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation.

Karen K. Fields, Gerald J. Elfenbein, Walter L. Trudeau,

Journal of Clinical Oncology

1996

183

Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas

X Zhang, X Chen, Jianhong Lin,

Oncogene

2011

153

Page 1